U.S. Pharma Stock News

SkyWater Technology (SKYT) has drawn fresh attention after reporting fourth quarter and full year 2025 results, with quarterly sales of US$171.04 million and a full year swing to net income of US$118.92 million. See our latest analysis for SkyWater Technology. The latest earnings update has come alongside a sharp shift in sentiment, with a 90 day share price return of 63.11% and a 1 year total shareholder return of 245.89%. This suggests momentum has built quickly despite a recent 5.72% 30...

Block (NYSE:XYZ) is cutting more than 4,000 jobs, over 40% of its workforce, as it shifts to an AI focused operating model. CEO Jack Dorsey describes the restructuring as a proactive reset aimed at reshaping how the company runs core technology and payments operations. The announcement has drawn strong attention from investors and the wider fintech sector, given the size and speed of the planned changes. For investors watching NYSE:XYZ, the move comes after a mixed share price record. The...

If you are wondering whether MercadoLibre is still worth the price tag at around US$1,714 per share, it helps to step back and look at what the current market is actually pricing in. The stock has seen sharp moves recently, with a 10.8% decline over the last 7 days, 20.2% over the last 30 days, and a 13.2% decline year to date. The 1 year return sits at a 16.8% decline, and the 3 and 5 year returns are 35.5% and 18.0% respectively. These swings come as MercadoLibre continues to feature in...

Harrow recently announced that the FDA has cleared its Investigational New Drug application for a Phase 3 trial of TRIESENCE, a preservative-free triamcinolone acetonide injectable, to evaluate safety and efficacy in treating ocular inflammation and pain following cataract surgery in a randomized, placebo-controlled, double-masked, multicenter study of about 250 patients. The planned trial targets the large and growing U.S. cataract surgery population and could, if successful, support...

Vir Biotechnology (VIR) is back in focus after its agreement with Astellas Pharma on prostate cancer candidate VIR-5500, along with fresh Phase 1 data and several recent equity financing moves. See our latest analysis for Vir Biotechnology. Despite a 4.6% 1-day share price decline to US$8.91 and some pressure over the past week, Vir Biotechnology’s roughly 20% 1-month and 42% 3-month share price returns suggest momentum has picked up around the Astellas partnership, Phase 1 VIR-5500 data and...

If you are wondering whether Dow's share price still reflects good value, the recent mix of gains and setbacks makes it an interesting name to look at closely. The stock trades at US$30.74, with a 1% decline over the last 7 days, an 11.6% gain over 30 days, a 26.7% gain year to date, and returns of a 7.9% decline over 1 year, a 34.2% decline over 3 years, and a 35.1% decline over 5 years. Recent coverage around Dow has focused on its role as a large materials company and its exposure to...

If you are wondering whether Marriott International's current share price offers fair value, this is a closer look at what the market might be pricing in. The stock recently closed at US$335.91, with returns of 6.5% over the last 30 days, 7.2% year to date, and longer term returns of 25.2% over 1 year, 99.4% over 3 years, and 137.4% over 5 years, which may influence how investors view its potential and risk. Recent news flow around Marriott International has focused on broader themes such as...

What the recent move in AllianceBernstein Holding (AB) means for investors AllianceBernstein Holding (AB) has drawn attention after recent returns that differ over shorter and longer periods. This has prompted investors to reassess how its current unit price and fundamentals fit into a diversified income and asset management portfolio. See our latest analysis for AllianceBernstein Holding. With the unit price at US$39.12, the recent 1-day and 7-day share price returns sit against a weaker...

Nabors Industries (NBR) has drawn fresh attention after recent trading, with the share price near $76.60 and performance over the past month and past 3 months contrasting with weaker multi year total returns. See our latest analysis for Nabors Industries. The current share price of US$76.60 comes after a 30 day share price return of 14.6% and a 90 day share price return of 39.45%. The 1 year total shareholder return of 99.38% contrasts with weaker 3 and 5 year total shareholder returns,...

Ford Motor (NYSE:F) has announced wide scale safety recalls affecting more than 4,000,000 trucks and SUVs in the United States. The recalls address software issues tied to braking and lighting systems, as well as hardware faults that may impact steering control. These actions introduce fresh questions around Ford's quality controls and potential financial and reputational impacts. For shareholders, these recalls come with Ford Motor trading at $12.7, after a 10.6% decline over the past week...

First Solar recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year on year, and issued 2026 guidance calling for US$4.9 billion to US$5.2 billion in net sales alongside planned module shipments of 17.0 GW to 18.2 GW. At the same time, the company secured a new US$1.50 billion unsecured revolving credit facility, enhancing financial flexibility as it pursues its manufacturing and growth plans. We’ll now examine how this strong 2025 earnings...

Coupang, Inc. has already reported fourth-quarter 2025 results, with revenue rising to US$8.84 billion but swinging from a prior-year profit to a US$26 million net loss, while full-year 2025 revenue increased to US$34.53 billion and net income to US$208 million. Alongside these results, Coupang completed a US$243.50 million share repurchase program and filed a US$1.88 billion shelf registration for employee stock offerings, highlighting an active mix of capital returns and equity...

In the past quarter, Cardinal Health reported revenue and earnings that exceeded analyst expectations, reflecting strong demand across its pharmaceutical and medical distribution operations and improved efficiency. An interesting angle for investors is how favorable valuation metrics and upgraded analyst assessments have highlighted Cardinal Health as a potential value-focused healthcare distributor with improving fundamentals. With these better-than-expected quarterly results highlighting...

In recent weeks, Ameriprise Financial has faced insider share sales by several top executives, the planned retirement of a key Advice & Wealth Management leader, and an SEC fine related to compliance failures involving unapproved electronic messaging platforms. At the same time, its Columbia Threadneedle asset management arm was ranked by Barron's among the top fund families across 1-, 5-, and 10-year periods, underscoring the group’s long-term investment performance. We’ll examine how the...

Cipher Digital (CIFR) is in the middle of a major business reset, moving from bitcoin mining to high performance computing data centers backed by long-term capacity leases and newly raised bond financing. See our latest analysis for Cipher Digital. Despite the pivot to high performance computing data centers and new long term leases, recent trading has been choppy, with a 1 day share price return of 6.66% decline and a 90 day share price return of 21.04% decline. This contrasts with a very...

Event context and recent share performance Arthur J. Gallagher (AJG) has been drawing attention after a period of mixed share performance, with the stock showing gains over the past week but declines over the past month, past 3 months, year to date, and past year. In this context, some investors are reassessing how the company’s current share price of $225.23 and its recent return profile align with its scale, with reported revenue of $13.0b and net income of $1.5b. See our latest analysis...

Pinnacle West Capital (PNW) has drawn fresh attention after recent share price moves, with the stock last closing at $102. Investors are weighing this level against the company’s fundamentals and recent return profile. See our latest analysis for Pinnacle West Capital. The recent move to a $102 share price sits within a stronger trend, with a 30 day share price return of 9.02% and a year to date share price return of 15.72%, alongside a 5 year total shareholder return of 63.94%. Together,...

Autoliv (NYSE:ALV) has announced that board members Mr. Franz-Josef Kortüm and Mr. Martin Lundstedt will not stand for re election at the next Annual Meeting. The upcoming departures will lead to changes in the company’s board composition and governance structure. For you as an Autoliv shareholder, these board changes come at a time when the stock trades around $113.07, with a value score of 6. The shares show mixed recent performance, with a 7% decline year to date and a 26.8% return over...

What is moving Applied Optoelectronics right now? Applied Optoelectronics (AAOI) has been drawing attention after a sharp share price move, with the stock returning 119% over the past month and 272% over the past 3 months. For investors, these rapid swings put a spotlight on how the business fundamentals, including recent revenue and net income trends, line up with the current US$95.34 share price. See our latest analysis for Applied Optoelectronics. That recent surge sits on top of a much...

New CEO’s transformation plan puts Ichor Holdings (ICHR) in focus A leadership shift at Ichor Holdings (NasdaqGS:ICHR), with a new CEO prioritizing operational discipline, margin expansion, and core semiconductor activities, has pushed the stock into the spotlight for investors reassessing the story. See our latest analysis for Ichor Holdings. The recent leadership change comes after a powerful run in Ichor Holdings’ share price, with a 90 day share price return of 159.2% and year to date...

Recent share performance and business snapshot Bank of N.T. Butterfield & Son (NTB) has seen mixed recent share performance, with a 1 day return of a 0.88% decline, a 7 day move of a 0.35% decline and a 1 month performance of a 1.89% decline. Over the past 3 months, the stock shows a 5.26% gain, with a year to date return of 2.25% and a 1 year total return of 39.34%. Longer term, 3 year and 5 year total returns stand at 67.26% and 73.29% respectively. The bank reports revenue of US$606.792...

Core Scientific (CORZ) just posted its FY 2025 Q4 numbers, reporting revenue of US$79.8 million, basic EPS of US$0.68 and net income of US$216.0 million. The company has seen quarterly revenue move in a tight band between US$78.6 million and US$95.4 million since late 2024, while basic EPS has swung from a loss of US$1.17 per share in 2024 Q3 to a profit of US$0.68 in 2025 Q4, highlighting how volatile margins have been for shareholders tracking the story. With trailing twelve month EPS still...

Enovis Corporation recently reported its fourth-quarter and full-year 2025 results, including sales of US$575.76 million for the quarter and US$2.25 billion for the year, alongside a goodwill impairment charge of US$501.31 million that kept the company in a loss-making position. At the same time, Enovis issued 2026 guidance calling for US$2.31 billion to US$2.37 billion in revenue and 4–6% organic growth, highlighting how ongoing product innovation and margin efforts are being weighed...

If you are wondering whether Church & Dwight is offering fair value at its current share price, you are not alone. This article is built to help you assess what you are really paying for. The stock last closed at US$103.02, with a 7.0% return over the past 30 days, a 24.7% return year to date, but a 5.7% decline over the past year and longer term returns of 27.6% over 3 years and 35.9% over 5 years. Recent interest in Church & Dwight reflects its position as a long established household...